Abbott India Ltd NSE:ABBOTINDIA:
APPOINTS MAITHILEE MISTRY AS CFO EFFECTIVE MAY 6, 2025
Abbott India Appoints Maithilee Mistry As CFO
Earlier from Abbott India
- Selloff in leading shares of drugmakers after Trump hints at tariffs on pharma imports
- ABBOTINDIA: Strong revenue and profit growth with robust margins and clean audit for the latest quarter
- ABBOTINDIA: Quarterly profit and revenue rose year-over-year, with robust margins and higher cash reserves
- Investors lose Rs 3.7 lakh crore as US Fed outlook, FII selling among top factors behind market sell-off
- ABBOTINDIA: Quarterly profit and revenue increased year-over-year, with strong cash and no audit concerns
Later from Abbott India
- Abbott India Says Swati Dalal Resigns As Managing Director
- ABBOTINDIA: Revenue up 9.6%, PAT up 17.8%, dividend at ₹475/share, strong portfolio growth
- Abbott India Reports Q4 Profit Of 3.67 Billion Rupees
- Abbott India jumps on strong quarterly results
- Buy Abbott India; target of Rs 35,750: ICICI Securities
Follow Abbott India into a list and get an email when it puts out news.
Follow Abbott India